T-cell receptor affinity for self-antigen has an important role in establishing self-tolerance. Three transgenic mouse strains expressing antigens of variable affinity for the OVA transgenic-I T-cell receptor were generated to address how TCR affinity affects the efficiency of negative selection, the ability to prime an autoimmune response, and the elimination of the relevant target cell. Mice expressing antigens with an affinity just above the negative selection threshold exhibited the highest risk of developing experimental autoimmune diabetes. The data demonstrate that close to the affinity threshold for negative selection, sufficient numbers of self-reactive T cells escape deletion and create an increased risk for the development of autoimmunity.
T cell | TCR | affinity | tolerance | autoimmunity A protective and self-tolerant T-cell repertoire is generated in the thymus (1) (2) (3) , where negative selection reduces the number of self-reactive thymocytes with autoimmune potential (4-6). However, negative selection is not a perfect process, and a small number of self-reactive T cells are found in the periphery (7) . Previous work from our laboratory defined the affinity threshold where negative selection is initiated (1, 8) . Thymocytes expressing MHC I restricted T-cell receptors (TCRs) undergoing negative selection when binding a self-antigen with a K d ≤ 6 μM and positive selection when binding a self-antigen with lower affinity (8, 9) .
The autoimmune regulator transcription factor ensures that tissue-restricted antigens are also expressed in the thymus within resident medullary thymic epithelial cells (mTECs) (10) ; however, individual self-antigens are expressed on only a small percentage of mTECs, and the presentation of a single antigen is limited on the mTEC or dendritic cell surface (11) (12) (13) (14) . Therefore, self-reactive T cells might stochastically escape negative selection (15) . A high frequency of self-reactive T cells in the peripheral repertoire correlates with the susceptibility to develop autoimmune disease. Studies showed that mice with high frequencies of myelin-specific T cells are more susceptible for the induction of experimental autoimmune encephalomyelitis compared with mice with lower frequencies of these cells (16) . In single transgenic mice expressing lymphocytic choriomeningitis virus (LCMV) glycoprotein (gp33) or nucleoprotein with a polyclonal T-cell repertoire, cytotoxic T lymphocytes (CTLs) generated during the immune response are of lower affinity compared with nontransgenic mice, suggesting that the highest affinity T cells for the neoantigen were removed from the T-cell repertoire by central tolerance (16) (17) (18) . Nevertheless, the remaining lower affinity T cells were capable of inducing diabetes upon LCMV infection. Similar findings have been reported for the rat insulin promoter (RIP)-membrane-bound form of ovalbumin (mOVA) mouse line coexpressing the OT-I TCR (OVA transgenic-I T-cell receptor) β-chain (17). Self-reactive T cells also play a role in the spontaneous development of diabetes in nonobese diabetic (NOD) mice (19) .
Recently, we reported a peripheral correlate of the thymic negative selection affinity threshold such that above-threshold ligands drive T cells into asymmetrical T-cell division, allowing them to differentiate into short-lived effector T cells (20) . Belowthreshold T cells expand less efficiently but can still threaten the host upon recognition of below-threshold antigen in an infectious environment (21) . In fact, below-threshold T cells are indeed able to mediate autoimmunity after immunization with recombinant Listeria monocytogenes (Lm) expressing a belowthreshold antigen (22) .
Antigen affinity affects important parameters related to the development of autoimmunity: (i) the efficiency of central tolerance, (ii) the efficiency of T-cell priming, and (iii) the efficiency of destroying a target cell expressing the self-antigen. In this study, we examined these parameters individually and in combination. We show a striking threshold effect on central deletion, T-cell priming, and cytolysis of antigen-expressing cells in the target tissue. These experiments demonstrate that T cells expressing TCRs just above the affinity threshold have the highest potential to induce an autoimmune disease. In RIP-OVA mice, the transgenic RIP drives OVA expression in pancreatic Langerhans islet β cells, proximal tubular epithelial cells in the kidney, mTECs in the thymus, and testes of male mice. For these studies, two different RIP-OVA lines were used: RIPsOVA and RIP-mOVA express the soluble and membrane forms of ovalbumin, respectively. We also generated three new strains of RIP-variant transgenic mice expressing the mOVA variants: Q4H7 (RIP-mQ4H7, below-threshold), T4 (RIP-mT4, threshold), and Q4R7 (RIP-mQ4R7, above-threshold). To determine whether OVA-variant antigens are expressed in pancreatic β cells, OT-I mice were crossed to the various RIP-OVA-variant mice to
Significance
The adaptive immune system has the potential to generate a self-reactive response, which can eventually lead to an autoimmune disease. To avoid this outcome, T lymphocytes with high-affinity, self-reactive antigen receptors are blocked from entering the mature T-cell pool (negative selection). Given this mechanism for removing dangerous high-affinity T cells, we wondered whether autoimmunity is more likely to be caused by chronic stimulation of low-affinity T cells or by stimulation of a few high-affinity T cells that escaped negative selection. In this paper, we show that T cells with an affinity just above the selection threshold can bypass negative selection and have the highest potential to cause an experimental autoimmune disease. generate double-transgenic F 1 animals (i.e., OT-I TCR × RIP-OVA F 1 , OT-I TCR × RIP-mQ4H7 F 1 , OT-I TCR × RIP-mT4 F 1 , and OT-I TCR × RIP-mQ4R7 F 1 ). Surprisingly, doubletransgenic F 1 mice of all crosses showed high mortality within the first 2 wk after birth (89% in OT-I × RIP-mQ4H7, 100% in OT-I × RIP-mT4, 97% in OT-I × RIP-mQ4R7, 72% in OT-I × RIP-mOVA, and 52% in OT-I × RIP-sOVA) (Fig. 1 ). Blood glucose levels of newborn mice were elevated in all crosses, indicating severe hyperglycemia. From these results, we conclude that all RIP-OVA-variant transgenic mice expressed the OVA protein in the β cells of the corresponding RIP-OVA strains and that central tolerance mechanisms were overwhelmed in these F 1 mice.
Below-Threshold T Cells Comprise a Low Risk of Autoimmunity. We wondered how target cell antigen affinity influences the development of diabetes following infection with a pathogen expressing a high-affinity epitope (i.e., molecular mimicry). Accordingly, we transferred OT-I T cells into RIP-variant mice, which were subsequently infected with Lm expressing the highest affinity OVA epitope (Lm-OVA). RIP-transgenic mice expressing threshold (RIPmT4) and above-threshold (RIP-mQ4R7, RIP-OVA) OVA variants developed diabetes when as few as 3 × 10 3 OT-I T cells were transferred ( Fig. 2A) . The transgenic strain RIP-mQ4H7 expressing the below-threshold variant Q4H7 did not develop diabetes; adoptive transfer of as many as 3 × 10 5 OT-I T cells did not result in glucosuria.
Autoimmune diseases can also be initiated by priming autoreactive T cells with self-antigens that are identical to the target antigen. Therefore, OT-I T cells were transferred into various RIPtransgenic strains, followed by immunization with Lm expressing the same OVA variant as is expressed in the host pancreas (Fig.  2B ). Because diabetes induction was similar in RIP-sOVA and RIP-mOVA mice, we combined them into one group (RIP-OVA). A breakdown of the two strains is provided in the legend for Fig. 2 . We observed efficient diabetes induction with only 3 × 10 3 transferred OT-I T cells in mice expressing above-threshold self-antigens (RIP-OVA: 100%, nine of nine mice; RIP-mQ4R7: 73%, eight of 11 mice). Strikingly, mice expressing the threshold variant, RIP-mT4, required 100-fold as many OT-I T cells (3 × 10 5 ) for diabetes induction. In contrast, there was no induction of diabetes in RIP-mQ4H7 mice expressing the below-threshold OVA variant. All transgenic lines receiving Lm, but no OT-I T cells, were free of diabetes (SI Appendix, Fig S6A) . These data demonstrate that when the immunizing and target antigens are identical, only abovethreshold antigens efficiently induce autoimmune diabetes.
Negative Selection Affinity Threshold Observed in Vivo. To study negative selection in these transgenic strains, we generated mixed bone marrow (BM) chimeras, in which a mixture of CD45.1 + B6 BM (70%) and CD45.1 + /.2 + OT-I Rag KO BM (30%) was injected into previously irradiated CD45.2 + transgenic RIP-variant hosts (Fig. 3A) . All chimeric mice were similarly reconstituted with OT-I BM (21-33%) (SI Appendix, Fig. S2 ). We assessed the frequency ( + OT-I T cells in the lymph nodes (LNs) of the reconstituted chimeras 12 wk after BM transfer. The extent of clonal deletion was calculated in each chimeric strain (legend for Fig. 3C ). Clonal deletion of OT-I T cells was not observed in RIP-mQ4H7 (below-threshold) or RIP-mT4 (threshold) hosts ( Fig. 3 B and C) . In contrast, the efficiency of clonal deletion was 91% in RIP-mQ4R7 (above-threshold) hosts and >99% in RIP-OVA (highest affinity) hosts (Fig. 3D ). Similar results were obtained when analyzing thymocytes from the various chimeric mice (SI Appendix, Fig. S3 ). Taken together, these data demonstrate an affinity threshold that dictates the efficiency of negative selection in vivo (Fig. 3D) . These results are similar to what we observed in fetal thymic organ culture (8) .
Phenotype of T Cells Escaping Negative Selection. We wondered whether OT-I T cells escaping negative selection in mice expressing above-threshold self-antigens (RIP-mQ4R7 and RIP-OVA) are phenotypically different from conventional OT-I cells. Analysis of LN cells revealed that only OT-I/B6 BM → RIP-OVA (high-affinity) chimeras contained elevated percentages of CD44 + (Fig. 4A ) and CD122 + OT-I cells (Fig. 4B ). Additionally these hosts contained increased frequencies of OT-I cells with memory phenotypes (Fig. 4) . The increase of these two memory populations was not correlated with negative selection per se, because they were not increased in negatively selecting RIPmQ4R7 hosts. Recently, Tsai et al. (23) + MHC I-restricted T cells is driven by high-affinity self-antigen (agonist selection) (24) (25) (26) (27) . These cells carry a suboptimal coreceptor and have likely bypassed negative selection.
Highest Potential for Autoimmunity Occurs Just Above the Affinity
Threshold. All chimeric mice were tolerant, because there was no sign of spontaneous autoimmune diabetes. To assess their risk of developing autoimmune diabetes, we immunized each chimeric strain with the corresponding self-peptide + LPS and plotted the incidence of diabetes vs. tetramer affinity (Fig. 5) . Responsiveness and RIP-mOVA (n = 3) mice.
of OT-I T cells to these peptides is shown in SI Appendix, Fig. S4 . OT-I/B6 BM → RIP-mQ4H7 chimeras immunized with Q4H7 peptide + LPS developed neither glucosuria nor lethal diabetes. On the other hand, 100% (eight of eight) OT-I/B6 BM → RIPmT4 chimeras immunized with the threshold peptide, T4 + LPS, developed glucosuria (Fig. 5A ) that resolved in 50% of these animals (compare gray symbols in Fig. 5 A and B) . In this model, the threshold ligand induces autoimmune symptoms but not always irreversible disease (50%). Considering above-threshold self-antigens, 86% of OT-I/B6 BM → RIP-mQ4R7 chimeras immunized with Q4R7 + LPS developed irreversible diabetes ( Fig. 5 A and B) . In contrast, not a single (none of 10) OT-I/B6 BM → RIP-OVA chimeras immunized with OVA peptide + LPS developed glucosuria or irreversible diabetes ( Fig. 5 A and B) . Unlike the RIP-mQ4R7 chimeras, the tolerant state in these highest affinity RIP-OVA chimeras is robust and stable. All chimeric strains, regardless of the affinity of their OVAvariant self-antigen, contained a similar frequency (SI Appendix, Fig. S6B ) of CD4
+

FoxP3
+ regulatory T cells (Tregs; derived from B6 donor BM). This finding was expected because the only difference between the RIP strains is an MHC class I-presented epitope. Therefore, Treg frequency does not explain the dramatic differences between the RIP-mQ4R7 and RIP-OVA chimeras in terms of susceptibility to developing autoimmune diabetes.
Self-Antigen Affinity vs. Risk of Developing Autoimmunity. Based on these results, we plotted self-antigen affinity vs. the number of peripheral OT-I cells and color-coded the risk to develop autoimmune diabetes upon self-antigen challenge (Fig. 6) . In Fig. 6A , the number of OT-I cells from each of the four strains of RIPvariant chimeric mice (from Figs. 3 and 5 ) is plotted vs. antigen affinity. In Fig. 6B , the risk of developing lethal diabetes was extrapolated to cover a wide range of self-antigen affinities and numbers of self-reactive peripheral T cells. We assumed that a chimeric mouse expressing a self-antigen of lower affinity compared with Q4H7 or containing lower numbers of peripheral OT-I T cells would also carry a very low risk (∼0%) of developing diabetes. Mice expressing a self-antigen at the affinity threshold have an intermediate (∼50%) risk of developing lethal autoimmunity, but only if they contain large numbers (∼2 × 10 6 ) of OT-I cells (sectors 2 and 3) (Figs. 2B and 5 ). In contrast, the risk of developing diabetes is very high (∼90%) in RIP-mQ4R7 chimeras. One can assume that chimeric mice expressing an even higher affinity self-antigen and containing ≥10 5 OT-I cells would also have a very high (≥90%) risk of developing this form of autoimmunity. Finally, RIP-OVA chimeras containing 6 × 10 3 OT-I T cells remain tolerant to a challenge with OVA + LPS. We assumed that chimeric mice containing as few as 6 × 10 3 OT-I cells and expressing a lower affinity self-antigen would also have a similarly low risk of developing autoimmune diabetes (sector 5).
In Fig. 6C , the hypothetical plot in Fig. 6B has been corrected for the effects of central tolerance. Because above-threshold selfantigens prevent most but not all self-reactive thymocytes from entering the periphery, the risk of developing autoimmunity is significantly reduced. As illustrated in Fig. 6C , we propose that the "dangerous" fraction of the peripheral T-cell repertoire is concentrated among T cells with a TCR affinity just above the negative selection threshold (i.e., K d of ∼6 μM). At this affinity, negative selection is incomplete and the escaping T cells have sufficient affinity to induce autoimmune diabetes in this model system (20) . At higher TCR affinities, negative selection is increasingly complete such that the few escaping T cells are incapable of inducing a lethal autoimmune disease.
Discussion
To address how self-antigen affinity influences several different steps in the establishment of T-cell tolerance, we generated new transgenic mouse strains expressing antigens with variable affinity for the OT-I TCR. All RIP-OVA-variant strains were crossed to OT-I cells to generate double-transgenic mice. All double-transgenic strains develop diabetes, indicating expression of the neo-self-antigen in the pancreas. The incidence of diabetes in RIP-mQ4H7, RIP-mT4, and RIP-mQ4R7 doubletransgenic mice is 89-100%, suggesting that tolerance mechanisms were overwhelmed. Lethal diabetes appears in only 52% of RIP-sOVA and 72% of RIP-mOVA double-transgenic mice, indicating that very high-affinity self-antigens more efficiently deplete self-reactive thymocytes. These results are consistent with observations of Hubert et al. (28) , who observed that 88% OT-I × RIP-mOVA double-transgenic mice develop severe diabetes. Similarly, McGargill et al. (29) found that 80% of K14-OVAp/OT-I double-transgenic mice, where OVA is expressed under control of the keratin promoter 14, succumb to a lethal autoimmune disease due to insufficient deletion of developing OT-I cells. Nevertheless, 20% of these animals survived. Surprisingly, double-transgenic animals expressing the below-threshold Self-antigen affinity (Fig. 3) is plotted vs. antigen affinity. The negative selection affinity threshold is indicated by an arrow. The risk of developing diabetes is indicated by color (blue, ∼0% risk; yellow, ∼50% risk; red, ∼90% risk). (B) Data in A are extrapolated for an extended range of self-antigen affinities and numbers of self-reactive OT-I T cells. A description of different regions of the plot is provided in Results. (C) Extrapolated plot in B is corrected for the effects of negative selection; central deletion removes most, but not all, OVA-reactive T cells with TCR affinities above the negative selection threshold (sector 6). In principle, this model could be applied to any self-reactive CD8 T cell.
antigen Q4H7 develop diabetes (8, 20, 22) . A possible explanation is that just after birth, an extremely large number of OT-I T cells likely enter the periphery before significant numbers of Tregs accumulate. In this relatively lymphopenic environment, a sufficient number of OT-I T cells might expand by homeostatic division within the first week of life, generating diabetogenic CTLs. In a mimicry model (30) (31) (32) , where transferred OT-I cells were fully activated following Lm-OVA (high-affinity) infection (33), RIP-mQ4H7 mice did not develop diabetes, indicating that host tissues expressing a below-threshold self-antigen are difficult to damage. All other RIP-OVA-variant mice efficiently developed lethal diabetes. Therefore, under conditions of molecular mimicry, host tissues expressing threshold or above-threshold self-antigens are highly susceptible to autoimmune attack. In a different setting, where the host experiences an infection of a peripheral organ, inflammation-induced tissue damage might result in release and presentation of self-tissue antigens, which subsequently induce a pathogenic response from self-antigen specific T cells that have survived negative selection. To address the role of antigen affinity in this context, RIP-OVA-and RIP-OVA-variant mice were adoptively transferred with OT-I cells and infected with Lm expressing the same OVA variant expressed by the self-antigen transgenic mouse. Mice expressing self-antigen above the affinity threshold (RIP-mQ4R7 and RIP-mOVA) are at high risk to develop diabetes, even when low numbers of OT-I cells were transferred. In contrast, mice expressing the threshold antigen T4 required 100-fold more transferred OT-I T cells to develop diabetes.
Many early studies examining tolerance to very high-affinity neo-self-antigens did not address tolerance to intermediateand low-affinity antigens (4, 16, 18, 34, 35) . More recent studies indicate that tolerance to intermediate-and low-affinity antigens is inefficient (17, 22) . To address this issue in a more quantitative manner, we generated mixed OT-I/B6 BM chimeric mice using RIP-OVA-variant hosts. Chimeras expressing below-threshold or at-threshold affinity antigens do not induce negative selection in vivo, whereas hosts expressing abovethreshold self-antigens are highly efficient in preventing OT-I T cells from entering the periphery (RIP-mQ4R7 = 91% efficient, RIP-mOVA > 99.5% efficient, RIP-sOVA > 99.4% efficient). We also observed deletion of self-reactive OT-I cells within the thymus, indicating that in chimeric mice, a large component of their tolerance is attributable to thymic selection processes (SI Appendix, Fig S3) . These results are similar to what we observed in fetal thymic organ culture (8) . It is worth noting that just above the affinity threshold, negative selection is incomplete.
Because agonist-selected thymocytes enter diverse T-cell lineages (36-41), we examined the phenotype of peripheral OT-I T cells in chimeric RIP-mOVA-variant mice. The frequency of CD8αα OT-I cells increased in chimeras expressing above-threshold antigens (42) (43) (44) (45) . Given their reduced antigen binding (46, 47) The highest potential for autoimmunity occurs near the affinity threshold for negative selection (RIP-mT4 chimeras: 50% irreversible diabetes, RIP-mQ4R7 chimeras: 86% irreversible diabetes). In contrast, below-threshold affinity chimeras (OT-I/ B6 BM → RIP-mQ4H7) and the highest affinity chimeras (OT-I/ B6 BM → RIP-mOVA and OT-I/B6 BM → RIP-sOVA) failed to develop diabetes. Below-threshold RIP-mQ4H7 chimeras are likely protected due to inefficient T-cell priming and poor target cell lysis. High-affinity RIP-mOVA and RIP-sOVA chimeras are likely protected due to extremely efficient negative selection. Interestingly, the highest risk of developing autoimmune diabetes in this model is just above the negative selection affinity threshold. In this narrow range of TCR affinity, negative selection is leaky and the escaping peripheral T cells can be sufficiently activated by their self-antigen to induce autoimmune pathology.
Under certain conditions, low-affinity T cells cause diabetes in an RIP-mOVA model. Enouz et al. (22) have convincingly shown that below-threshold antigens induce peripheral CD8 T cells to differentiate into CTLs; furthermore, these below-threshold stimulated T cells cause hyperglycemia in mice expressing a threshold affinity antigen in the pancreas. The experiments described here were slightly different; although T cells can be stimulated by a below-threshold antigen, such T cells do not induce diabetes in mice expressing the same below-threshold antigen on pancreatic β cells. Therefore, our results are not inconsistent with the results reported by Enouz et al. (22) . Our data make the important point that it is quantitatively more difficult to induce autoimmune pathology using a below-threshold antigen compared with an abovethreshold antigen.
The frequency of lethal diabetes is high in this model (50% for chimeras expressing a threshold antigen, 86% for chimeras expressing an above threshold antigen). This observation is likely due to the fact that the chimeras were reconstituted with a large fraction (30%) of stem cells derived from OT-I mice. In contrast, the frequency of self-reactive thymocytes for a single epitope is much smaller in polyclonal individuals, which likely improves the efficiency of thymic deletion. This idea is consistent with the relatively low incidence of autoimmunity in the general population; 3% of the human population suffers from some form of autoimmunity (48) . Nevertheless, an individual can probably cope with a small number of high-affinity peripheral T cells and still be considered functionally tolerant, allowing negative selection to be less than perfect, which seems to be the case (49, 50) . Recent computational studies (51) propose that an immune or autoimmune response requires a minimum (quorum) number of antigen-specific T cells. If an individual carries fewer than the quorum number of abovethreshold T cells for a particular epitope, it may be extremely difficult to induce an autoimmune disease. Our studies suggest that T cells with an antigen affinity just above the affinity threshold are more likely to exceed the quorum number in the periphery. For this reason, T cells with self-reactivity just above the negative selection threshold have the highest autoimmune potential.
Materials and Methods
Mice. RIP-sOVA and RIP-mOVA mice (20, 52, 53) , OT-I TCR transgenic mice recognizing K b /Ova 257-264 , and CD45-1 congenic C57BL/6 mice were all obtained from the Jackson Laboratory. All animal work was done in accordance with the federal and cantonal laws of Switzerland. Animal research protocols were approved by the Animal Research Commission of the Canton of Baselstadt, Switzerland. Generation of OVA-variant transgenic mice. Generation of OVA-variant transgenic mice is described in SI Appendix, Fig S1 .
Generation of BM chimeric mice. Generation of BM chimeric mice is described in SI Appendix, Fig S2. Adoptive Cell Transfer and Infections. Mice were injected i.v. with single-cell suspensions of OT-I cells; on the following day, 5,000 cfu of Lm-OVA or Lm-OVA variant was injected i.v.. Recombinant Lm expressing the full-length OVA protein containing the CD8 epitope SIINFEKL (OVA) or altered ligands Q4R7, T4, or Q4H7 was previously described (21) .
